https://www.ema.europa.eu/en/homepageHuman medicines: European public assessment reports (EPARs)en-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 12:33:22 +0200Fri, 28 Jun 2024 14:41:00 +0200https://www.ema.europa.eu/en/medicines/human/variation/cresembaSummary of opinion: Cresemba, 27/06/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/cresembaFri, 28 Jun 2024 14:41:00 +0200Human medicine and SMOPshttps://www.ema.europa.eu/en/medicines/human/variation/vabysmoSummary of opinion: Vabysmo, 27/06/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/vabysmoFri, 28 Jun 2024 12:00:45 +0200Human medicine and SMOPshttps://www.ema.europa.eu/en/medicines/human/variation/tepkinlySummary of opinion: Tepkinly, 27/06/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/tepkinlyFri, 28 Jun 2024 12:00:41 +0200Human medicine and SMOPshttps://www.ema.europa.eu/en/medicines/human/variation/beyfortusSummary of opinion: Beyfortus, 27/06/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/beyfortusFri, 28 Jun 2024 12:00:38 +0200Human medicine and SMOPshttps://www.ema.europa.eu/en/medicines/human/variation/betmigaSummary of opinion: Betmiga, 27/06/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/betmigaFri, 28 Jun 2024 12:00:25 +0200Human medicine and SMOPshttps://www.ema.europa.eu/en/medicines/human/variation/imcivree-0Summary of opinion: Imcivree, 27/06/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/imcivree-0Fri, 28 Jun 2024 12:00:03 +0200Human medicine and SMOPshttps://www.ema.europa.eu/en/medicines/human/variation/pegasysSummary of opinion: Pegasys, 27/06/2024 Positivehttps://www.ema.europa.eu/en/medicines/human/variation/pegasysFri, 28 Jun 2024 12:00:00 +0200Human medicine and SMOPs